Inicio>>Signaling Pathways>> Tyrosine Kinase>> IGF1R>>Figitumumab

Figitumumab (Synonyms: CP-751871)

Catalog No.GC69112

Figitumumab (CP-751871) es un anticuerpo monoclonal humano eficaz contra el receptor 1 del factor de crecimiento similar a la insulina (IGF1R). Figitumumab puede bloquear la unión de IGF1 con IGF1R, con una IC50 de 1.8 nM.

Products are for research use only. Not for human use. We do not sell to patients.

Figitumumab Chemical Structure

Cas No.: 943453-46-1

Tamaño Precio Disponibilidad Cantidad
5mg
900,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties Product Documents

Reseñas

Review for Figitumumab

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Figitumumab

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.